What is Availity and is it a medication?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Availity is Not a Medication

Availity is not a medication—it is a healthcare technology platform used for administrative and billing functions in the United States healthcare system. There appears to be confusion in your question, as none of the provided medical evidence relates to "Availity" as a pharmaceutical agent.

What Availity Actually Is

Availity is a digital clearinghouse and portal system that healthcare providers, payers, and vendors use for:

  • Insurance eligibility verification
  • Claims submission and status tracking
  • Prior authorization requests
  • Electronic remittance advice
  • Provider-payer communication

Possible Confusion with Auvelity

You may be confusing "Availity" with Auvelity (dextromethorphan-bupropion), which IS a medication. Auvelity is an FDA-approved oral medication for treating major depressive disorder (MDD) in adults, approved in August 2022 1, 2.

Key Facts About Auvelity (if this is what you meant):

  • Mechanism: NMDA receptor antagonist and sigma-1 receptor agonist (dextromethorphan) combined with bupropion, which increases dextromethorphan bioavailability through CYP2D6 inhibition 2

  • Efficacy: Demonstrated significant reductions in Montgomery-Åsberg Depression Rating Scale scores within 2 weeks, with remission rates approaching 70% in long-term studies 2

  • Real-world use: In the first year post-approval, 28.8% of patients initiated it as monotherapy, while 71.2% used it as add-on therapy, most commonly with SSRIs or SNRIs 1

  • Tolerability: Well-tolerated with mostly mild-to-moderate adverse events 2

Please clarify whether you are asking about the healthcare technology platform Availity or the antidepressant medication Auvelity, as these are entirely different entities.

References

Research

Dextromethorphan-bupropion (Auvelity) for the Treatment of Major Depressive Disorder.

Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.